Some small European governments are turning to China for Covid-19 vaccines, as European Union purchases stumble and production hiccups from Western vaccine manufacturers hamper the continent’s fight against the pandemic.
The trend may increase China’s influence in the region as it campaigns to present itself as a trusted ally in the fight against the coronavirus that was first detected in its soil.
The European Union, which buys vaccines on behalf of its 27 member states, has authorized three vaccines developed in Germany, the United States and the United Kingdom. But the bloc was slow to sign contracts and authorize vaccines, while manufacturers struggle to deliver the promised doses. The scarcity was even worse in non-EU countries in Europe.
So far, it is mainly the small nations on the bloc’s margins that have turned to Beijing for help. However, as voters’ frustrations escalate, larger members are now considering two vaccines from China and one developed in Russia.
On January 31, German Health Minister Jens Spahn asked the EU to approve the injection made by China’s Sinopharm Group, if it is found to be safe and effective. Then Austrian Chancellor Sebastian Kurz said the company should manufacture its shots in his country.